Seattle Genetics, Inc. (SGEN)
Seattle Genetics, Inc. (SGEN)
$75.07 USD
Updated Jul 19 12:00am
Add SGEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
SGEN News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesSeattle Genetics, Inc. (SGEN) Company Bio
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. The company was founded in 1998 and is based in Bothell, Washington.
SGEN Stock Chart More Charts
SGEN Price/Volume Stats
| Current price | $75.07 |
| Prev. close | $76.64 |
| Day low | $74.69 |
| Day high | $77.06 |
| 50-day MA | $68.37 |
| 200-day MA | $67.93 |
| 52-week high | $84.37 |
| 52-week low | $50.71 |
| Volume | 1,560,700 |
| Avg. volume | 890,245 |
| Dividend yield | N/A |
| Market Cap | 12.14B |
SGEN Returns
| 1-mo | 3.79% |
| 3-mo | 8.51% |
| 6-mo | 1.98% |
| 1-year | 6.85% |
| 3-year | 72.97% |
| 5-year | 119.05% |
| YTD | 32.49% |
| 2018 | 5.91% |
| 2017 | 1.38% |
| 2016 | 17.58% |
| 2015 | 39.68% |
| 2014 | -19.45% |
Loading social stream, please wait...